Drug Interaction Data Earn New Contraindications for Tizanidine

A link to the FDA alert and the company's letter is available at www.fda.gov/medwatch/safety/2007/safety07.htm#Zanaflex. Report serious reactions to Acorda at 800-367-5109 or by e-mail at: Acorda@medcomsol.com, or to the FDA's MedWatch program, which is located online at www.fda.gov/medwatch.